Investor profile
Red Cell Partners
VC
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Red Cell Partners is a hybrid incubation and investment firm that creates, launches, and scales rapidly scalable technology companies in three practice areas: healthcare, cyber, and national security. Rather than spreading capital across a large number of companies, Red Cell methodically identifies, builds, and funds a concentrated portfolio of high-conviction companies from the first dollar up — often filling early C-suite roles itself — to ensure each is properly capitalized, achieves product-market fit, and secures initial commercial traction before seeking external funding. The firm targets dual-use companies serving both commercial and government customers, aiming to generate alpha by controlling its own deal flow and maintaining significant ownership at a low cost basis as companies scale.
Notable quotes
“Red Cell's approach represents a compelling and bold model where the firm, more so than most, controls its own destiny. Rather than spreading our investments across a large number of companies in the hope that a select few will have outsized success over a 10-year-plus period, Red Cell methodically identifies, builds, and funds a smaller number of companies, ensuring that each one is properly capitalized and equipped to meet product-development and customer-acquisition milestones.”
“If you're an amazing engineer, why don't we help you with finance, marketing, legal? Whatever it is that you have, we want to surround you with the things that you need and can help build value as you try to change the world.”
“We think we can bring a lot to the table in terms of democratizing data. Let's create this system infrastructure and start to be more predictive for value-based outcomes.”
Team
Grant Verstandig
Founder, Chairman & CEO
Yisroel Brumer
Founding Partner; Co-Founder & CEO, DEFCON AI
George Barnes
President, Cyber Practice
Honorable Veronica Daigle
President, National Security Practice
Eric Ossola
Investment Principal
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Claros | Seed | $30m | 2026-03-19 |
| Valinor Enterprises | Venture Round | $25m | 2026-02-05 |
| Evoke Security | Early Stage VC | — | 2026-01-21 |
| Hunted Labs | Seed | $3m | 2025-03-19 |
| Zephyr AI | Series A | $111m | 2024 |
| DEFCON AI | Seed | $44m | 2024 |
| Andesite | Seed | — | 2023 |
| Epirus | Early Stage VC | — | 2021 |
| Red 6 | Other Equity | $7m | 2021-03-01 |
| Envisagenics | Later Stage VC | — | 2024-07-18 |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| Bessemer Venture Partners | 2 |
| General Catalyst | 2 |
| Founders Fund | 1 |
| Narya Capital | 1 |
| XYZ Venture Capital | 1 |
| Snowpoint Ventures | 1 |
Fit check
Is Red Cell Partners a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit